ArticleInsights into imaging2026
Deep learning-based early prediction of carotid plaque response to lipid-lowering therapy using longitudinal multimodal ultrasound imaging.
Article in Insights into imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveThis study aimed to develop and validate a deep learning prediction model using longitudinal multimodal ultrasound imaging for early identification of treatment-sensitive and treatment-resistant carotid plaques in patients receiving lipid-lowering therapy. MATERIALS AND
methodsThis prospective study enrolled 802 patients with vulnerable carotid plaques or stenosis ≥ 50%. Patients underwent serial multimodal ultrasound examinations, including B-mode imaging, superb microvascular imaging, and shear wave elastography at baseline and 3, 6, 9, and 12 months after initiating statin therapy. The dataset was divided into training and testing sets using stratified sampling with data augmentation. A hybrid DL model combining convolutional neural networks and long short-term memory networks analyzed longitudinal imaging sequences integrated with baseline clinical data. Five progressive prediction models were constructed for baseline and each follow-up time point, sharing identical architecture but trained independently on temporal sequences of varying lengths using 5-fold cross-validation. Model performance was assessed for discrimination ability, calibration consistency, and clinical utility.
resultsFive progressive prediction models demonstrated characteristic temporal performance patterns, with significant improvement from 3 to 6 months (AUC 0.866), followed by marginal gains. The 6-month model emerged as the most clinically practical assessment time point, achieving high specificity (93.7%) for early therapeutic decisions. Ablation experiments confirmed imaging features as primary predictive determinants, while attention mapping revealed consistent focus on plaque-adjacent regions, validating that treatment response prediction relies on morphological changes within target plaques.
conclusionA hybrid DL model enables reliable carotid plaque treatment response prediction within six months, optimizing personalized therapy through earlier identification of treatment-resistant patients. CRITICAL RELEVANCE: This study validates deep learning algorithms to predict carotid plaque treatment response within six months, advancing clinical radiology practice by enabling earlier therapeutic optimization through objective ultrasound-based assessment. KEY POINTS: Conventional imaging requires 12 months to reliably assess plaque treatment response. Deep learning model predicts treatment response at six months with high accuracy. Earlier prediction enables timely therapeutic adjustments for resistant patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.